BioLineRx Receives Orphan Drug Designation from the FDA for Lead Candidate BL-8040 for the Treatment of Pancreatic Cancer – CBI
Homepage /  Press Release /  BioLineRx Receives Orphan Drug Designation from the FDA for Lead Candidate BL-8040 for the Treatment of Pancreatic Cancer

Press Release

BioLineRx Receives Orphan Drug Designation from the FDA for Lead Candidate BL-8040 for the Treatment of Pancreatic Cancer